Table 1.

Overall and disease-free survival

First author	Overall survival						Disease-free survival
	Median (months)	1 year (%)	2 years (%)	3 years (%)	5 years (%)	10 years (%)	Median (months)	1 year (%)	2 years (%)	3 years (%)	5 years (%)	10 years (%)
Harrison [38]	32	80	–	45	37	–	–	–	–	–	–	18.7
Lindell [27]	32	75	–	–	36	25	–	–	–	–	–	–
Elias [24]	–	–	–	–	36	–	–	–	–	–	28	–
Berney [19]	19	61	43	–	27	–	36a	–	–	–	–	–
Hamy [22]	19.6	54 ± 8	42 ± 8	–	27 ± 8	–	–	–	–	–	–	–
Benevento [25]	38 ± 11	54	42	–	21	–	–	–	–	–	–	–
Hemming [40]	46	85	–	55	45	–	28a	–	–	–	–	–
Takada [23]	0–53	–	–	–	–	–	–	–	–	–	–	–
Van Ruth [18]	21	–	–	–	35	–	12	–	–	–	20	–
Laurent [30]	–	81	–	40	35	–	–	–	–	–	–	–
Goering [20]	45	82	–	55	39	–	–	43	–	21	–	–
Karavias [28]	–	–	–	78	–	–	–	–	–	–	–	–
Torras [33]	–	86	48	–	–	–	53 ± 38	50	25	–	–	–
Yedibela [16]	23	–	49	–	26	–	25	–	–	–	–	–
Weitz [35]	42	–	–	57	–	–	17	–	–	30	–	–
Cordera [31]	28.8	81.1	–	43	30.2	–	13.2	64.7	–	–	15.8	–
Earle [17]	36	88.5	–	49.1	34.9	–	21.5	–	–	–	–	–
Adam [37]	35	–	–	–	36	23	13	–	–	–	21	15
Verhoef [21]	37	–	–	–	42	–	–	–	–	–	–	–
Lendoire [34]	27	67	–	34	19	–	–	–	–	–	–	–
O’Rourke [29]	42	–	–	56.1	38.5	–	18	–	–	37.2	26.5	–
Pais Costa [32]	–	–	–	50	–	–	–	–	–	40	–	–
Ercolani [41]	35.5 ± 6.4	83.6	–	56.5	40	–	26.6 ± 4.1	75	–	44	30	–
Duan [26]	38.8 ± 26.7	84.8	–	44.7	29.5	–	–	–	–	–	–	–
Bresadola [39]	20	71.9	–	42.8	28.9	–	19–44	68–85	–	29–63	19–52	–
Marudanayagam [42]	19	72.9	–	47.9	25.6	–	19	–	–	–	–	–
Treska [15]	–	88.6	–	72.5	36.9	–	–	–	–	–	–	–
Groeschl [36]	49	73	–	50	31	–	23	–	–	–	–	–
Slotta [43]	20.5	66	–	43	30	–	–	–	–	–	39	–
Takemura [44]	41.8	83.9	–	55.4	41	–	10	43.7	–	21.1	18.1	–
Range	0–53				19–42	23–25	10–53				15.8–52	15–18.7
Average	32.3				32.3	24	23.1				26	16.9

^aOnly metachronous group